James Young
Chairman chez NOVAVAX, INC.
Fortune : 335 030 $ au 31/03/2024
Provenance du réseau au premier degré de James Young
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.
73
| Subsidiary | Biotechnology | 73 |
| Public Company | Biotechnology | 56 | |
| Public Company | Pharmaceuticals: Major | 19 | |
Icahn School of Medicine at Mount Sinai
10
| College/University | Other Consumer Services | 10 |
| Subsidiary | Biotechnology | 5 | |
| Subsidiary | Agricultural Commodities/Milling | 4 | |
| Public Company | Biotechnology | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à James Young via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BAXTER INTERNATIONAL INC. | Medical Specialties | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing General Counsel Private Equity Investor | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| GENVEC INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Chairman Chairman | |
| INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Conceptis Technologies, Inc.
 Conceptis Technologies, Inc. Internet Software/ServicesTechnology Services Part of WebMD Health Corp., Conceptis Technologies, Inc. is a Canadian company that provides online and offline medical education and promotion aimed at physicians. The private company is based in Montréal, Canada. Conceptis Technologies was acquired by Emdeon Corp. on December 02, 2005 for $19.86 million. | Internet Software/Services | Chairman Director of Finance/CFO | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | President Founder Private Equity Investor Corporate Officer/Principal | |
| VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member | |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Chairman Founder | |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Virginia | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Dartmouth College | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal General Counsel | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| American University | College/University | Undergraduate Degree Graduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree Director/Board Member Director/Board Member Graduate Degree Masters Business Admin Undergraduate Degree | |
| Lehigh University | College/University | Undergraduate Degree Graduate Degree | |
| Princeton University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| University of Illinois | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
| Georgetown University | College/University | Masters Business Admin Corporate Officer/Principal Undergraduate Degree | |
| EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Public Communications Contact General Counsel General Counsel | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| DNAX Research, Inc. | Corporate Officer/Principal Corporate Officer/Principal | ||
| ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Chief Administrative Officer Director of Finance/CFO Chief Operating Officer | |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Stanford Law School | College/University | Graduate Degree Graduate Degree | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Chairman Corporate Officer/Principal Founder Corporate Officer/Principal | |
Learning Undefeated, Inc.
 Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Learning Undefeated, Inc. is a non-profit organization that provides STEM education opportunities for underserved communities. The non-profit company is based in Gaithersburg. The American company's flagship education program features mobile STEM labs that have provided hands-on learning opportunities to more than 200,000 K-12 students in 18 states since 2003. The company also operates several other celebrated STEM education programs including the Young Science Explorers program, a summer camp for middle school students, and the Advancing Tomorrow's Leaders in STEM (ATLAS) college and career exploration program. Learning Undefeated is driving race and gender equity in STEM through experiential and deep-impact learning experiences for students from under-resourced communities. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Chairman | |
| BRII BIOSCIENCES LIMITED | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
| Etats-Unis | 48 |
| Royaume-Uni | 2 |
| Canada | 2 |
| Chine | 2 |
Sectorielle
| Health Technology | 25 |
| Consumer Services | 17 |
| Finance | 4 |
| Commercial Services | 4 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 314 |
| Corporate Officer/Principal | 245 |
| Independent Dir/Board Member | 85 |
| Undergraduate Degree | 85 |
| Chief Executive Officer | 79 |
Relations les plus connectées
| Insiders | |
|---|---|
| David Mott | 45 |
| Rajiv Indravadan Modi | 31 |
| Gail Boudreaux | 30 |
| Lori Kunkel | 27 |
| Gary Evans | 25 |
| Peter Kiener | 25 |
| Rahul Singhvi | 22 |
| Gregg Alton | 22 |
| Wayne T. Hockmeyer | 22 |
| Fred Driscoll | 21 |
| Gordon Ringold | 20 |
| Jinzi Wu | 20 |
| Christopher Krueger | 20 |
| Hal R. Werner | 17 |
| Atul Saran | 17 |
- Bourse
- Insiders
- James Young
- Connexions Sociétés
